Purificación Martínez de Prado

First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Eduardo Díaz‐Rubio, Auxiliadora Gómez‐España, Bartomeu Massutí et al. · The Oncologist · 2012 · 212 citations · Full text

Medicine, Oncology, Pharmacology +12

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Jean‐François Emile, Catherine Julié, Karine Le Malicot et al. · European Journal of Cancer · 2017 · 46 citations · Full text

Medicine, Immunology, Oncology +17

Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study

Eduardo Díaz‐Rubio, Auxiliadora Gómez‐España, Bartomeu Massutí et al. · PLoS ONE · 2012 · 41 citations · Full text

Medicine, Oncology, Pharmacology +14

A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry

Alberto Carmona‐Bayonas, David Gómez, Eva Martínez de Castro et al. · European Journal of Internal Medicine · 2020 · 39 citations · Full text

Medicine, Oncology, Cancer Epidemiology +14

Plasma amino acids in children from Guadalajara with kwashiorkor

H. Padilla, R. N. Powell, Chisae Umezawa et al. · American Journal of Clinical Nutrition · 1971 · 29 citations

Agriculture, Nutrition, Pediatrics +8